Carroll Financial Associates’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$23K Buy
246
+56
+29% +$6.01K ﹤0.01% 938
2021
Q3
$24K Sell
190
-68
-26% -$9.52K ﹤0.01% 947
2021
Q2
$39K Sell
258
-188
-42% -$24.8K ﹤0.01% 882
2021
Q1
$47K Buy
446
+306
+219% +$30.6K ﹤0.01% 786
2020
Q4
$11K Buy
140
+22
+19% +$1.61K ﹤0.01% 1089
2020
Q3
$6K Buy
+118
New +$6.36K ﹤0.01% 1166

Other funds holding STAA

Carroll Financial Associates's STAA Position: Q4 2021 in Review

Carroll Financial Associates increased its STAAR Surgical (STAA) stake by 29% in Q4 2021, buying an estimated $6.01K and bringing the position to 246 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Carroll Financial Associates first reported a position in STAA in Q3 2020 and has held it in 6 quarters since. The position peaked at $47K in Q1 2021. 280 funds tracked by Wall St. Rank hold STAA as of Q4 2021.

  • Carroll Financial Associates held 246 shares of STAAR Surgical worth $23K as of Q4 2021.
  • Carroll Financial Associates bought 56 STAAR Surgical shares in Q4 2021, an estimated $6.01K.
  • STAAR Surgical made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #938 holding.
  • Carroll Financial Associates first reported a position in STAAR Surgical in Q3 2020 and has held it in 6 quarters since.
  • Carroll Financial Associates's STAAR Surgical position peaked at $47K in Q1 2021.
  • 280 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.